M. Paprskářová

The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.

M. Hajdúch, P. Džubák, M. Paprskářová, 2010, Neoplasma.

4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.

P. Fischer, G. Kontopidis, M. Hajdúch, 2006, Journal of medicinal chemistry.

Functional p53 in cells contributes to the anticancer effect of the cyclin‐dependent kinase inhibitor roscovitine

J. Węsierska‐Gądek, M. Strnad, V. Kryštof, 2009, Journal of cellular biochemistry.

Classical Anticytokinins Do Not Interact with Cytokinin Receptors but Inhibit Cyclin-dependent Kinases*

D. Inzé, T. Schmülling, P. Fischer, 2007, Journal of Biological Chemistry.

Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin.

M. Strnad, L. Havlícek, V. Kryštof, 2006, European journal of medicinal chemistry.